Aurobindo Pharma reports stellar Q1 numbers

08 Aug 2014 Evaluate

Aurobindo Pharma has reported results for first quarter ended June 30, 2014.

The company’s net profit after tax has jumped around three fold at Rs 393.40 crore as compared to Rs 143.63 crore for the quarter ended June 30, 2013. Its total income has increased by 21.19% to Rs 1956.69 crore for the quarter under review from Rs 1614.61 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported over 22 fold jump in its net profit after taxes and minority interest at Rs 415.43 crore for the quarter as compared to Rs 18.60 crore for the same quarter in the previous year. Its total income has increased by 69.93% at Rs 2921.88 crore for quarter under review as compared to Rs 1719.48 crore for the quarter ended June 30, 2013.

During the quarter Agile Pharma B.V-Netherlands, a step down subsidiary of the company has acquired select Western European business of Actavis. The above consolidated results for the current quarter ended June 30, 2014 includes the results of the operation of the above business of Actavis from April 01, 2014. The corresponding figures for the previous periods are not comparable.

Aurobindo Pharma Share Price

1181.20 -6.00 (-0.51%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×